59. When researchers are studying the effect of new drug treatments on patients, bias can be introduced by patients if they are aware of who receives the placebo. Which type of research design eliminates this type of bias?

Answer: A

Explanation:

Blind study eliminates bias related to patient awareness of treatment assignment.

A blind study ensures that patients do not know whether they are receiving the treatment or the placebo, which helps minimize bias in their responses and perceptions during the research.

A) Blind study

Blind studies are specifically designed to prevent participants from knowing whether they are receiving the actual treatment or a placebo. This lack of awareness reduces the likelihood of biases affecting the patients' behavior and reporting, ultimately leading to more reliable and valid results.

B) Time series study

A time series study involves repeated observations of the same variables over time. While it can demonstrate trends and changes, it does not address the issue of participant awareness regarding treatment, allowing for the possibility of bias through patient expectations or reactions.

C) Observational study

Observational studies involve watching and recording behavior without manipulating any variables. However, this type of study does not eliminate bias from patients knowing their treatment status, which can skew the data collected through their subjective experiences.

D) Prospective cohort study

A prospective cohort study follows a group of individuals over time to see how certain exposures affect outcomes. Similar to observational studies, this design does not inherently prevent bias stemming from patients being aware of whether they are receiving the treatment or placebo.

Conclusion

A blind study is the most effective design for eliminating bias associated with patients' awareness of treatment assignment. All other options, while useful in their own contexts, do not adequately address the potential for bias that could arise from patients knowing whether they are receiving the placebo or the active treatment. This distinction is crucial for ensuring the integrity of the research findings.